CD274 and neoplasm: Notably, the PD-L1+TIL− tumor tends to develop resistance to monotherapy of anti-PD-L1, as the absence of TILs limits the effectiveness of ICB, while PD-L1 blockade in combination with other therapy increasing T cell infiltration in tumor bed would reduce resistance (Teng et al., 2015).